14 July 2022 | News
Advised to sell drugs only after a valid prescription of a registered practitioner
Image Credit: Shutterstock
The Central Consumer Protection Authority (CCPA), under Ministry of Consumer Affairs, Government of India, has issued an advisory to e-commerce entities concerning the sale of Ayurvedic, Siddha and Unani drugs containing ingredients listed in Schedule E (1) of the Drugs and Cosmetics Rules, 1945.
E-commerce platforms have been advised that the sale or facilitating of the sale of such drugs shall be done only after a valid prescription of a registered Ayurveda, Siddha or Unani practitioner respectively is uploaded by the user on the platform. Consuming such drugs without medical supervision can lead to severe health complications.
As per Rule 161(2) of the Drugs and Cosmetics Rules, 1945, the container of a medicine for internal use for the treatment of human ailments shall, if it is made up of a substance specified in Schedule E (1), be labelled conspicuously with the words “Caution: To be taken under medical supervision” both in English and Hindi language.